GORDON CARL L

Reported to SECin USFilings at 4 companies

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 39. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 39
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
ADARx Pharmaceuticals, Inc.—Conversionnothing paid256,448 sharesSep 30, 2026ADARx Pharmaceuticals, Inc.nothing paidConversion · Sep 30Conversion256,448Sep 30, 2026
ADARx Pharmaceuticals, Inc.—Conversionnothing paid513,067 sharesSep 30, 2026ADARx Pharmaceuticals, Inc.nothing paidConversion · Sep 30Conversion513,067Sep 30, 2026
ADARx Pharmaceuticals, Inc.—Conversionnothing paid1,333,975 sharesSep 30, 2026ADARx Pharmaceuticals, Inc.nothing paidConversion · Sep 30Conversion1,333,975Sep 30, 2026
ADARx Pharmaceuticals, Inc.—Conversionnothing paid7,127,019 sharesSep 30, 2026ADARx Pharmaceuticals, Inc.nothing paidConversion · Sep 30Conversion7,127,019Sep 30, 2026
ADARx Pharmaceuticals, Inc.—Conversionnothing paid564,187 sharesSep 30, 2026ADARx Pharmaceuticals, Inc.nothing paidConversion · Sep 30Conversion564,187Sep 30, 2026